DEBRA SAFRIT: Open Payments
NPI 1720069917 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,247 in 65 payments from 19 companies in 2025. Trend: 2023 $540 · 2024 $983 · 2025 $1,247
Food & beverage: $1,247
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $178 |
| Novo Nordisk Inc | 7 | $138 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $105 |
| ABBVIE INC. | 5 | $95 |
| Aimmune Therapeutics, Inc. | 3 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $89 |
| Lilly USA, LLC | 4 | $84 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| PFIZER INC. | 4 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
Products named: FARXIGA, XIFAXAN, Ozempic, ZENPEP, MOUNJARO, AIRSUPRA, TRELEGY ELLIPTA, Kerendia.
Industry payments across NC — which companies pay providers there.
